Literature DB >> 33400859

Assessing pulmonary circulation in severe bronchopulmonary dysplasia using functional echocardiography.

Arvind Sehgal1,2, Douglas Blank1,2, Calum T Roberts1,2, Samuel Menahem3, Stuart B Hooper4,5.   

Abstract

Pulmonary hypertension (PH) is common in infants with severe bronchopulmonary dysplasia (BPD) and increases the risk of death. The objectives of this preliminary study were to compare responses of pulmonary circulation parameters to 100% oxygen (O2 ) and inhaled nitric oxide (iNO) in infants with BPD and PH using echocardiography. Responses between fetal growth restriction (FGR) and appropriate for gestational age infants were compared. Ten infants <28 weeks GA at birth were assessed at ≥36 weeks corrected gestation. Baseline echocardiography1 was performed which was repeated (echocardiography2) after 30 minutes of O2 . After a gap of 2-3 hours, iNO was administered for 15 minutes and echocardiography3 was performed, followed by iNO weaning. The gestation and birthweight of the cohort were 25.9 ± 1.6 weeks and 612 ± 175 g. Assessments were performed at 38.7 ± 1.4 weeks corrected gestational age. Baseline time to peak velocity: right ventricular ejection time (TPV/RVETc) increased from 0.24 ± 0.02 to 0.27 ± 0.02 (O2 , p = .01) and 0.31 ± 0.03 (iNO, p < .001), indicating a decrease in pulmonary vascular resistance [PVR]. Baseline tricuspid annular plane systolic excursion (TAPSE) increased from 8.1 ± 0.6 mm to 9.3 ± 0.7 mm (O2 , p = .01) and 10.5 ± 1.1 mm (iNO, p = .0004), indicating improved ventricular systolic performance. Percentage change for all parameters was greater with iNO. Significant correlations between cardiac performance and PVR were noted. FGR infants noted higher baseline PVR (TPV/RVETc, 0.21 ± 0.02 vs. 0.25 ± 0.01, p = .002), lower ventricular performance (TAPSE, 7 ± 1.2 mm vs. 8.6 ± 6 mm, p = .003), and lower percentage change with O2 and iNO. A reactive component of pulmonary circulation provides real-time physiological information, which could rationalize treatment decisions.
© 2021 The Authors. Physiological Reports published by Wiley Periodicals LLC on behalf of The Physiological Society and the American Physiological Society.

Entities:  

Keywords:  bronchopulmonary dysplasia; fetal growth restriction; nitric oxide; pulmonary hypertension

Mesh:

Substances:

Year:  2021        PMID: 33400859      PMCID: PMC7785052          DOI: 10.14814/phy2.14690

Source DB:  PubMed          Journal:  Physiol Rep        ISSN: 2051-817X


  56 in total

Review 1.  Evaluation and Management of Pulmonary Hypertension in Children with Bronchopulmonary Dysplasia.

Authors:  Usha Krishnan; Jeffrey A Feinstein; Ian Adatia; Eric D Austin; Mary P Mullen; Rachel K Hopper; Brian Hanna; Lew Romer; Roberta L Keller; Jeffrey Fineman; Robin Steinhorn; John P Kinsella; D Dunbar Ivy; Erika Berman Rosenzweig; Usha Raj; Tilman Humpl; Steven H Abman
Journal:  J Pediatr       Date:  2017-06-20       Impact factor: 4.406

2.  Cardiorespiratory Physiology following Minimally Invasive Surfactant Therapy in Preterm Infants.

Authors:  Arvind Sehgal; Risha Bhatia; Calum T Roberts
Journal:  Neonatology       Date:  2019-09-05       Impact factor: 4.035

3.  Acute Vasodilator Response in Pediatric Pulmonary Arterial Hypertension: Current Clinical Practice From the TOPP Registry.

Authors:  Johannes M Douwes; Tilman Humpl; Damien Bonnet; Maurice Beghetti; D Dunbar Ivy; Rolf M F Berger
Journal:  J Am Coll Cardiol       Date:  2016-03-22       Impact factor: 24.094

4.  Acute Vasoreactivity Testing during Cardiac Catheterization of Neonates with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension.

Authors:  Benjamin S Frank; Michal Schäfer; Alicia Grenolds; D Dunbar Ivy; Steven H Abman; Jeffrey R Darst
Journal:  J Pediatr       Date:  2019-03-11       Impact factor: 4.406

Review 5.  Pulmonary vascular disease in bronchopulmonary dysplasia: pulmonary hypertension and beyond.

Authors:  Peter M Mourani; Steven H Abman
Journal:  Curr Opin Pediatr       Date:  2013-06       Impact factor: 2.856

6.  Effects of rho-kinase inhibition on pulmonary hypertension, lung growth, and structure in neonatal rats chronically exposed to hypoxia.

Authors:  Adrian J A Ziino; Julijana Ivanovska; Rosetta Belcastro; Crystal Kantores; Emily Z Xu; Mandy Lau; Patrick J McNamara; A Keith Tanswell; Robert P Jankov
Journal:  Pediatr Res       Date:  2010-02       Impact factor: 3.756

7.  Right Ventricular Function in Infants with Bronchopulmonary Dysplasia: Association with Respiratory Sequelae.

Authors:  Arvind Sehgal; Andra Malikiwi; Eldho Paul; Kenneth Tan; Samuel Menahem
Journal:  Neonatology       Date:  2016-02-18       Impact factor: 4.035

Review 8.  Echocardiographic assessment of pulmonary hypertension: standard operating procedure.

Authors:  Luke S Howard; Julia Grapsa; David Dawson; Michael Bellamy; John B Chambers; Navroz D Masani; Petros Nihoyannopoulos; J Simon R Gibbs
Journal:  Eur Respir Rev       Date:  2012-09-01

9.  Preterm growth restriction and bronchopulmonary dysplasia: the vascular hypothesis and related physiology.

Authors:  Arvind Sehgal; Stella M Gwini; Samuel Menahem; Beth J Allison; Suzanne L Miller; Graeme R Polglase
Journal:  J Physiol       Date:  2018-06-13       Impact factor: 5.182

10.  Patients with congenital systemic-to-pulmonary shunts and increased pulmonary vascular resistance: what predicts postoperative survival?

Authors:  Hui-Li Gan; Jian-Qun Zhang; Qi-Wen Zhou; Lei Feng; Fei Chen; Yi Yang
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

View more
  1 in total

Review 1.  PATET ratio by Doppler echocardiography: noninvasive detection of pediatric pulmonary arterial hypertension.

Authors:  Jennifer K Trittmann; Hanadi Almazroue; Leif D Nelin; Terri A Shaffer; Charanda R Celestine; Henry W Green; Raphael A Malbrue
Journal:  Pediatr Res       Date:  2021-11-18       Impact factor: 3.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.